Skip to main content
S&P 5007,551.81-0.45%DOW51,461.90-1.21%NASDAQ25,978.42-0.01%BTC$76,346.00+0.85%ETH$2,420.07+0.87%GOLD$4,327.00-1.38%OIL$101.32-1.08%
Smart Investors Daily
PH

NASDAQ · PHGE

BiomX Inc.

Healthcare · Biotechnology

$1.85

Up+$0.23 (+14.20%)

Updated Sep 17, 2026, 5:36 AM

SID Score

4.5/10

Composite research score

Smart Money

—

Institutional and insider signal

Market cap
3.74M
P/E ratio
-0.11
Dividend yield
0.00%
52-week range
$0.12 – $12.29
Volume
3.4M
Avg. volume
70.53K

Price performance

PHGE price history

1M range · 16 trading sessions · Daily adjusted prices

PHGE closed at $1.85 after 16 trading sessions, up 1253.33% for the selected period.

Last close
$1.85
Period change
+1253.33%
Period low
$0.13
Period high
$1.85
Daily close
View OHLC price history
PHGE OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Sep 10, 2026$1.66$2.1575$1.65$1.853.4M
Sep 9, 2026$1.60$1.72$1.50$1.62745.65K
Sep 8, 2026$0.15$0.165$0.1443$0.1556.53M
Sep 4, 2026$1.417$1.486$1.371$1.477210.65K
Sep 3, 2026$1.39$1.455$1.33$1.421249.59K
Sep 2, 2026$0.1435$0.145$0.13$0.14253.36M
Sep 1, 2026$0.1394$0.146$0.1316$0.1434.29M
Aug 31, 2026$0.143$0.143$0.131$0.13712M
Aug 28, 2026$0.134$0.1495$0.1301$0.13843.48M
Aug 27, 2026$0.131$0.134$0.13$0.1322369.34K
Aug 26, 2026$0.1336$0.1345$0.1303$0.131920.67K
Aug 25, 2026$0.1357$0.1388$0.13$0.135649.31K
Aug 24, 2026$0.1379$0.1379$0.1316$0.1341588.25K
Aug 21, 2026$0.134$0.14$0.134$0.1375966.36K
Aug 20, 2026$0.1382$0.14$0.137$0.1397961.25K
Aug 19, 2026$0.134$0.1409$0.1325$0.1367602.59K

Latest PHGE news

The latest Smart Investors Daily articles mentioning PHGE.

Stock researchCompany · Overview

PHGE research

Overview

Company profile and research snapshot.

Company profile

BiomX Inc is engaged in developing both natural and engineered phage cocktails and personalized treatments designed to target and destroy harmful bacteria in chronic diseases, including cystic fibrosis and diabetic foot osteomyelitis. It discovers and validates proprietary bacterial targets and customizes phage compositions against these targets, and applies its BOLT (BacteriOphage Lead to Treatment) platform to customize phage compositions against these targets. BX004 is its therapeutic phage product candidate under development for chronic pulmonary infections caused by Pseudomonas aeruginosa, or P. aeruginosa, a main contributor to morbidity and mortality in patients with CF. Its BX211 - Treatment of Diabetic Foot Osteomyelitis (DFO).

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
Buy
Average target
$2.00
Implied upside
—
Analysts
8
PHGE recent ratings
DateFirmRatingTarget
Mar 9, 2026HC Wainwright & Co.Neutral—
Nov 26, 2025HC Wainwright & Co.Buy—
Nov 25, 2025HC Wainwright & Co.Buy—
Aug 20, 2025HC Wainwright & Co.Buy—
May 16, 2025HC Wainwright & Co.Buy—
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Sep 11, 2026

Tessera Begins Trading Under HLSQ as Demand Grows for Connected Physical Security

Company begins trading under HLSQ; completes rebrand to become an integrated platform serving digital infrastructure, energy, critical infrastructure and homeland securityNETANYA, Israel, Sept. 11, 2026 (GLOBE NEWSWIRE) -- Tessera Defense and Homeland Security Inc. (NYSE American: HLSQ), formerly BiomX Inc. (NYSE American: PHGE) (“Tessera” or the “Company”), today announced that its corporate name and ticker symbol changes are now effective, completing its rebrand as a physical security technolo

Yahoo · Sep 4, 2026

BiomX: Zorronet Launches No-Code Control Over AI-Powered Autonomous Response Workflows

New capability lets operational teams connect existing cameras, sensors and physical systems into site-specific response logic - and change it on screen without code, software releases or developer supportNETANYA, Israel, Sept. 04, 2026 (GLOBE NEWSWIRE) -- BiomX Inc., to be renamed Tessera Defense and Homeland Security Inc. effective September 11, 2026 (NYSE American: PHGE; HLSQ from September 11, 2026) (“BiomX” or the “Company”), a company focused on defense, security and critical infrastructur

Yahoo · Sep 1, 2026

BiomX Inc. to Become Tessera Defense and Homeland Security Inc.

Name change effective September 11, 2026; common stock to trade on the NYSE American under the new symbol “HLSQ”NETANYA, Israel, Sept. 01, 2026 (GLOBE NEWSWIRE) -- BiomX Inc. (NYSE American: PHGE) (the “Company”) today announced that it will change its corporate name to Tessera Defense and Homeland Security Inc., effective at 12:01 a.m., Eastern Time, on September 11, 2026. The Company’s common stock will trade on the NYSE American under the new ticker symbol “HLSQ.” The new name completes the C

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.

Featured By